(Q53380756)

English

Enzyme replacement therapy improves joint motion and outcome of the 12-min walk test in a mucopolysaccharidosis type VI patient previously treated with bone marrow transplantation.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22495825

Enzyme replacement therapy improves joint motion and outcome of the 12-min walk test in a mucopolysaccharidosis type VI patient previously treated with bone marrow transplantation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22495825

enzyme replacement therapy

0 references

author name string

Young Bae Sohn

1

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22495825

Sung Won Park

2

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22495825

Se-Hwa Kim

3

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22495825

Sung-Yoon Cho

4

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22495825

Sun-Tae Ji

5

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22495825

Eun Kyung Kwon

6

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22495825

Sun Ju Han

7

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22495825

Se Jung Oh

8

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22495825

Yong Jae Park

9

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22495825

Ah-Ra Ko

10

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22495825

Kyung-Hoon Paik

11

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22495825

Jeehun Lee

12

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22495825

Dong Hwan Lee

13

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22495825

Dong-Kyu Jin

14

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22495825

language of work or name

0 references

publication date

11 April 2012

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22495825

American Journal of Medical Genetics

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22495825

158A

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22495825

5

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22495825

1158-1163

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22495825

Correction of human mucopolysaccharidosis type-VI fibroblasts with recombinant N-acetylgalactosamine-4-sulphatase

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35263

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35263

21 January 2018

Management guidelines for mucopolysaccharidosis VI.

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35263

21 January 2018

Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-ac

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35263

21 January 2018

Enzyme replacement therapy for mucopolysaccharidosis VI: evaluation of long-term pulmonary function in patients treated with recombinant human N-acetylgalactosamine 4-sulfatase

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35263

21 January 2018

Bone marrow transplantation for Maroteaux-Lamy syndrome (MPS VI): long-term follow-up.

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35263

21 January 2018

Advances in the treatment of mucopolysaccharidosis type I.

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35263

21 January 2018

Mucopolysaccharidosis I: management and treatment guidelines

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35263

21 January 2018

Short-term growth hormone treatment in children with Hurler syndrome after hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35263

21 January 2018

Growth and endocrine function in patients with Hurler syndrome after hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35263

21 January 2018

Transplant outcomes in mucopolysaccharidoses

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35263

21 January 2018

Mucopolysaccharidosis VI.

1 reference

https://api.crossref.org/works/10.1002%2FAJMG.A.35263

21 January 2018

Identifiers

10.1002/AJMG.A.35263

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22495825

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 May 2018

http://europepmc.org/abstract/MED/22495825

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53380756&oldid=965261053"